Search

Your search keyword '"Schlotz, Maike"' showing total 26 results
Start Over Author "Schlotz, Maike"
26 results on '"Schlotz, Maike"'

1. Dynamics and durability of HIV-1 neutralization are determined by viral replication

Author

Schommers, Philipp, Kim, Dae Sung, Schlotz, Maike, Kreer, Christoph, Eggeling, Ralf, Hake, Anna, Stecher, Melanie, Park, Juyeon, Radford, Caelan E., Dingens, Adam S., Ercanoglu, Meryem S., Gruell, Henning, Odidika, Stanley, Dahlhaus, Marten, Gieselmann, Lutz, Ahmadov, Elvin, Lawong, Rene Y., Heger, Eva, Knops, Elena, Wyen, Christoph, Kümmerle, Tim, Römer, Katja, Scholten, Stefan, Wolf, Timo, Stephan, Christoph, Suárez, Isabelle, Raju, Nagarajan, Adhikari, Anurag, Esser, Stefan, Streeck, Hendrik, Duerr, Ralf, Nanfack, Aubin J., Zolla-Pazner, Susan, Geldmacher, Christof, Geisenberger, Otto, Kroidl, Arne, William, Wiston, Maganga, Lucas, Ntinginya, Nyanda Elias, Georgiev, Ivelin S., Vehreschild, Jörg J., Hoelscher, Michael, Fätkenheuer, Gerd, Lavinder, Jason J., Bloom, Jesse D., Seaman, Michael S., Lehmann, Clara, Pfeifer, Nico, Georgiou, George, and Klein, Florian

Published
2023
Full Text
View/download PDF

3. Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients

Author

Dewald, Felix, Pirkl, Martin, Paluschinski, Martha, Kühn, Joachim, Elsner, Carina, Schulte, Bianca, Knüfer, Jacqueline, Ahmadov, Elvin, Schlotz, Maike, Oral, Göksu, Bernhard, Michael, Michael, Mark, Luxenburger, Maura, Andrée, Marcel, Hennies, Marc Tim, Hafezi, Wali, Müller, Marlin Maybrit, Kümpers, Philipp, Risse, Joachim, Kill, Clemens, Manegold, Randi Katrin, von Frantzki, Ute, Richter, Enrico, Emmert, Dorian, Monzon-Posadas, Werner O., Gräff, Ingo, Kogej, Monika, Büning, Antonia, Baum, Maximilian, Teipel, Finn, Mochtarzadeh, Babak, Wolff, Martin, Gruell, Henning, Di Cristanziano, Veronica, Burst, Volker, Streeck, Hendrik, Dittmer, Ulf, Ludwig, Stephan, Timm, Jörg, and Klein, Florian

Published
2023
Full Text
View/download PDF

4. Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients

Author

Klussmann, Jens Peter, Grosheva, Maria, Meiser, Peter, Lehmann, Clara, Nagy, Eszter, Szijártó, Valéria, Nagy, Gábor, Konrat, Robert, Flegel, Michael, Holzer, Frank, Groß, Dorothea, Steinmetz, Charlotte, Scherer, Barbara, Gruell, Henning, Schlotz, Maike, Klein, Florian, de Aragão, Paula Aguiar, Morr, Henning, Al Saleh, Helal, Bilstein, Andreas, Russo, Belisa, Müller-Scholtz, Susanne, Acikel, Cengizhan, Sahin, Hacer, Werkhäuser, Nina, Allekotte, Silke, and Mösges, Ralph

Published
2023
Full Text
View/download PDF

5. Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel

Author

Harries, Manuela, Jaeger, Veronika K., Rodiah, Isti, Hassenstein, Max J., Ortmann, Julia, Dreier, Maren, von Holt, Isabell, Brinkmann, Melanie, Dulovic, Alex, Gornyk, Daniela, Hovardovska, Olga, Kuczewski, Christina, Kurosinski, Marc-André, Schlotz, Maike, Schneiderhan-Marra, Nicole, Strengert, Monika, Krause, Gérard, Sester, Martina, Klein, Florian, Petersmann, Astrid, Karch, André, and Lange, Berit

Published
2024
Full Text
View/download PDF

6. Safe and effective pool testing for SARS-CoV-2 detection

Author

Wunsch, Marie, Aschemeier, Dominik, Heger, Eva, Ehrentraut, Denise, Krüger, Jan, Hufbauer, Martin, Syed, Adnan S, Horemheb-Rubio, Gibran, Dewald, Felix, Fish, Irina, Schlotz, Maike, Gruell, Henning, Augustin, Max, Lehmann, Clara, Kaiser, Rolf, Knops, Elena, Silling, Steffi, and Klein, Florian

Published
2021
Full Text
View/download PDF

7. Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Author

Mendoza, Pilar, Gruell, Henning, Nogueira, Lilian, Pai, Joy A., Butler, Allison L., Millard, Katrina, Lehmann, Clara, Suárez, Isabelle, Oliveira, Thiago Y., Lorenzi, Julio C. C., Cohen, Yehuda Z., Wyen, Christoph, Kümmerle, Tim, Karagounis, Theodora, Lu, Ching-Lan, Handl, Lisa, Unson-O’Brien, Cecilia, Patel, Roshni, Ruping, Carola, Schlotz, Maike, Witmer-Pack, Maggi, Shimeliovich, Irina, Kremer, Gisela, Thomas, Eleonore, Seaton, Kelly E., Horowitz, Jill, West, Jr, Anthony P., Bjorkman, Pamela J., Tomaras, Georgia D., Gulick, Roy M., Pfeifer, Nico, Fätkenheuer, Gerd, Seaman, Michael S., Klein, Florian, Caskey, Marina, and Nussenzweig, Michel C.

Published
2018
Full Text
View/download PDF

8. Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome

Author

Augustin, Max, primary, Heyn, Ferdinand, additional, Ullrich, Stella, additional, Sandaradura de Silva, Ute, additional, Albert, Marie-Christine, additional, Linne, Viktoria, additional, Schlotz, Maike, additional, Schommers, Philipp, additional, Pracht, Elisabeth, additional, Horn, Carola, additional, Suarez, Isabelle, additional, Simonis, Alexander, additional, Picard, Lea Katharina, additional, Zoufaly, Alexander, additional, Wenisch, Christoph, additional, Fätkenheuer, Gerd, additional, Gruell, Henning, additional, Klein, Florian, additional, Hallek, Michael, additional, Walczak, Henning, additional, Rybniker, Jan, additional, Theobald, Sebastian J., additional, and Lehmann, Clara, additional

Published
2023
Full Text
View/download PDF

9. Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

Author

Henze, Larissa, primary, Braun, Julian, additional, Meyer-Arndt, Lil, additional, Jürchott, Karsten, additional, Schlotz, Maike, additional, Michel, Janine, additional, Grossegesse, Marica, additional, Mangold, Maike, additional, Dingeldey, Manuela, additional, Kruse, Beate, additional, Holenya, Pavlo, additional, Mages, Norbert, additional, Reimer, Ulf, additional, Eckey, Maren, additional, Schnatbaum, Karsten, additional, Wenschuh, Holger, additional, Timmermann, Bernd, additional, Klein, Florian, additional, Nitsche, Andreas, additional, Giesecke-Thiel, Claudia, additional, Loyal, Lucie, additional, and Thiel, Andreas, additional

Published
2023
Full Text
View/download PDF

10. Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients

Author

Dewald, Felix, primary, Pirkl, Martin, additional, Ahmadov, Elvin, additional, Paluschinski, Martha, additional, Kühn, Joachim, additional, Elsner, Carina, additional, Schulte, Bianca, additional, Schlotz, Maike, additional, Oral, Göksu, additional, Knüfer, Jacqueline, additional, Bernhard, Michael, additional, Michael, Mark, additional, Luxenburger, Maura, additional, Andrée, Marcel, additional, Hennies, Marc Tim, additional, Hafezi, Wali, additional, Müller, Marlin Maybrit, additional, Kümpers, Philipp, additional, Risse, Joachim, additional, Kill, Clemens, additional, Manegold, Randi Katrin, additional, Frantzki, Ute von, additional, Richter, Enrico, additional, Emmert, Dorian, additional, Monzon-Posadas, Werner O., additional, Gräff, Ingo, additional, Kogej, Monika, additional, Büning, Antonia, additional, Baum, Maximilian, additional, Teipel, Finn, additional, Mochtarzadeh, Babak, additional, Wolff, Martin, additional, Gruell, Henning, additional, Cristanziano, Veronica Di, additional, Burst, Volker, additional, Streeck, Hendrik, additional, Dittmer, Ulf, additional, Ludwig, Stephan, additional, Timm, Jörg, additional, and Klein, Florian, additional

Published
2023
Full Text
View/download PDF

11. COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN) Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients – results from a randomized, double-blind, placebo-controlled phase II clinical trial.

Author

Klussmann, Jens, primary, Grosheva, Maria, additional, Meiser, Peter, additional, Lehmann, Clara, additional, Nagy, Eszter, additional, Szijártó, Valéria, additional, Nagy, Gábor, additional, Konrat, Robert, additional, Flegel, Michael, additional, Holzer, Frank, additional, Groß, Dorothea, additional, Steinmetz, Charlotte, additional, Scherer, Barbara, additional, Gruell, Henning, additional, Schlotz, Maike, additional, Klein, Florian, additional, de Aragão, Paula Aguiar, additional, Morr, Henning, additional, Saleh, Helal Al, additional, Bilstein, Andreas, additional, Russo, Belisa, additional, Müller-Scholtz, Susanne, additional, Acikel, Cengizhan, additional, Sahin, Hacer, additional, Werkhäuser, Nina, additional, Allekotte, Silke, additional, and Mösges, Ralph, additional

Published
2022
Full Text
View/download PDF

12. Probabilities of HIV-1 bNAb development in healthy and chronically infected individuals

Author

Kreer, Christoph, primary, Lupo, Cosimo, additional, Ercanoglu, Meryem S., additional, Gieselmann, Lutz, additional, Spisak, Natanael, additional, Grossbach, Jan, additional, Schlotz, Maike, additional, Schommers, Philipp, additional, Gruell, Henning, additional, Dold, Leona, additional, Beyer, Andreas, additional, Nourmohammad, Armita, additional, Mora, Thierry, additional, Walczak, Aleksandra M., additional, and Klein, Florian, additional

Published
2022
Full Text
View/download PDF

13. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia

Author

Mellinghoff, Sibylle C., primary, Mayer, Leonie, additional, Robrecht, Sandra, additional, Weskamm, Leonie M., additional, Dahlke, Christine, additional, Gruell, Henning, additional, Schlotz, Maike, additional, Vanshylla, Kanika, additional, Schloser, Hans A., additional, Thelen, Martin, additional, Fink, Anna-Maria, additional, Fischer, Kirsten, additional, Klein, Florian, additional, Addo, Marylyn M., additional, Eichhorst, Barbara, additional, Hallek, Michael, additional, and Langerbeins, Petra, additional

Published
2022
Full Text
View/download PDF

14. No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults

Author

Ercanoglu, Meryem Seda, Gieselmann, Lutz, Daehling, Sabrina, Poopalasingam, Nareshkumar, Detmer, Susanne, Koch, Manuel, Korenkov, Michael, Halwe, Sandro, Kluever, Michael, Di Cristanziano, Veronica, Janicki, Hanna, Schlotz, Maike, Worczinski, Johanna, Gathof, Birgit, Gruell, Henning, Zehner, Matthias, Becker, Stephan, Vanshylla, Kanika, Kreer, Christoph, Klein, Florian, Ercanoglu, Meryem Seda, Gieselmann, Lutz, Daehling, Sabrina, Poopalasingam, Nareshkumar, Detmer, Susanne, Koch, Manuel, Korenkov, Michael, Halwe, Sandro, Kluever, Michael, Di Cristanziano, Veronica, Janicki, Hanna, Schlotz, Maike, Worczinski, Johanna, Gathof, Birgit, Gruell, Henning, Zehner, Matthias, Becker, Stephan, Vanshylla, Kanika, Kreer, Christoph, and Klein, Florian

Abstract

Preexisting immunity against SARS-CoV-2 may have critical implications for our understanding of COVID-19 susceptibility and severity. The presence and clinical relevance of a preexisting B cell immunity remain to be fully elucidated. Here, we provide a detailed analysis of the B cell immunity to SARS-CoV-2 in unexposed individuals. To this end, we extensively investigated SARS-CoV-2 humoral immunity in 150 adults sampled pre-pandemically. Comprehensive screening of donor plasma and purified IgG sampler, for bin Jing and neutralization in various functional assays revealed no substantial activity against SARS-CoV-2 but broad reactivity to endemic betacoronaviruses. Moreover, we analyzed antibody sequences of 8,174 putatively SARS-CoV-2-reactive B cells at a single cell level and generated and tested 158 monoclonal antibodies. None of these antibodies displayed relevant binding or neutralizing activity against SARS-CoV-2. Taken together, our results show no evidence of competent preexisting antibody and B cell immunity against SARS-CoV-2 in unexposed adults.

Published
2022

15. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia

Author

Mellinghoff, Sibylle C., Mayer, Leonie, Robrecht, Sandra, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Schlotz, Maike, Vanshylla, Kanika, Schloesser, Hans A., Thelen, Martin, Fink, AnnaMaria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, Langerbeins, Petra, Mellinghoff, Sibylle C., Mayer, Leonie, Robrecht, Sandra, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Schlotz, Maike, Vanshylla, Kanika, Schloesser, Hans A., Thelen, Martin, Fink, AnnaMaria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, and Langerbeins, Petra

Published
2022

16. No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults

Author

Ercanoglu, Meryem Seda, primary, Gieselmann, Lutz, additional, Dähling, Sabrina, additional, Poopalasingam, Nareshkumar, additional, Detmer, Susanne, additional, Koch, Manuel, additional, Korenkov, Michael, additional, Halwe, Sandro, additional, Klüver, Michael, additional, Di Cristanziano, Veronica, additional, Janicki, Hanna, additional, Schlotz, Maike, additional, Worczinski, Johanna, additional, Gathof, Birgit, additional, Gruell, Henning, additional, Zehner, Matthias, additional, Becker, Stephan, additional, Vanshylla, Kanika, additional, Kreer, Christoph, additional, and Klein, Florian, additional

Published
2022
Full Text
View/download PDF

17. No substantial pre-existing B cell immunity against SARS-CoV-2 in healthy adults

Author

Ercanoglu, Meryem Seda, primary, Gieselmann, Lutz, additional, Daehling, Sabrina, additional, Poopalasingam, Nareshkumar, additional, Detmer, Susanne, additional, Koch, Manuel, additional, Korenkov, Michael, additional, Halwe, Sandro, additional, Kluever, Michael, additional, Di Cristanziano, Veronica, additional, Janicki, Ursula Hanna, additional, Schlotz, Maike, additional, Worczinski, Johanna, additional, Gathof, Birgit, additional, Gruell, Henning, additional, Zehner, Matthias, additional, Becker, Stephan, additional, Vanshylla, Kanika, additional, Kreer, Christoph, additional, and Klein, Florian, additional

Published
2021
Full Text
View/download PDF

18. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Author

Vanshylla, Kanika, primary, Di Cristanziano, Veronica, additional, Kleipass, Franziska, additional, Dewald, Felix, additional, Schommers, Philipp, additional, Gieselmann, Lutz, additional, Gruell, Henning, additional, Schlotz, Maike, additional, Ercanoglu, Meryem S., additional, Stumpf, Ricarda, additional, Mayer, Petra, additional, Zehner, Matthias, additional, Heger, Eva, additional, Johannis, Wibke, additional, Horn, Carola, additional, Suárez, Isabelle, additional, Jung, Norma, additional, Salomon, Susanne, additional, Eberhardt, Kirsten Alexandra, additional, Gathof, Birgit, additional, Fätkenheuer, Gerd, additional, Pfeifer, Nico, additional, Eggeling, Ralf, additional, Augustin, Max, additional, Lehmann, Clara, additional, and Klein, Florian, additional

Published
2021
Full Text
View/download PDF

19. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Author

Vanshylla, Kanika, Di Cristanziano, Veronica, Kleipass, Franziska, Dewald, Felix, Schommers, Philipp, Gieselmann, Lutz, Gruell, Henning, Schlotz, Maike, Ercanoglu, Meryem S., Stumpf, Ricarda, Mayer, Petra, Zehner, Matthias, Heger, Eva, Johannis, Wibke, Horn, Carola, Suarez, Isabelle, Jung, Norma, Salomon, Susanne, Eberhardt, Kirsten Alexandra, Gathof, Birgit, Faetkenheuer, Gerd, Pfeifer, Nico, Eggeling, Ralf, Augustin, Max, Lehmann, Clara, Klein, Florian, Vanshylla, Kanika, Di Cristanziano, Veronica, Kleipass, Franziska, Dewald, Felix, Schommers, Philipp, Gieselmann, Lutz, Gruell, Henning, Schlotz, Maike, Ercanoglu, Meryem S., Stumpf, Ricarda, Mayer, Petra, Zehner, Matthias, Heger, Eva, Johannis, Wibke, Horn, Carola, Suarez, Isabelle, Jung, Norma, Salomon, Susanne, Eberhardt, Kirsten Alexandra, Gathof, Birgit, Faetkenheuer, Gerd, Pfeifer, Nico, Eggeling, Ralf, Augustin, Max, Lehmann, Clara, and Klein, Florian

Abstract

Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody dynamics over 10 months in 963 individuals who predominantly experienced mild COVID-19. Investigating 2,146 samples, we initially detected SARS-CoV-2 antibodies in 94.4% of individuals, with 82% and 79% exhibiting serum and IgG neutralization, respectively. Approximately 3% of individuals demonstrated exceptional SARS-CoV-2 neutralization, with these elite neutralizers also possessing SARS-CoV-1 cross-neutralizing IgG. Multivariate statistical modeling revealed age, symptomatic infection, disease severity, and gender as key factors predicting SARS-CoV-2-neutralizing activity. A loss of reactivity to the virus spike protein was observed in 13% of individuals 10 months after infection. Neutralizing activity had half-lives of 14.7 weeks in serum versus 31.4 weeks in purified IgG, indicating a rather long-term IgG antibody response. Our results demonstrate a broad spectrum in the initial SARS-CoV-2-neutralizing antibody response, with sustained antibodies in most individuals for 10 months after mild COVID-19.

Published
2021

20. Safe and effective pool testing for SARS-CoV-2 detection

Author

Wunsch, Marie, primary, Aschemeier, Dominik, additional, Heger, Eva, additional, Ehrentraut, Denise, additional, Krüger, Jan, additional, Hufbauer, Martin, additional, Syed, Adnan S., additional, Horemheb-Rubio, Gibran, additional, Dewald, Felix, additional, Fish, Irina, additional, Schlotz, Maike, additional, Gruell, Henning, additional, Augustin, Max, additional, Lehmann, Clara, additional, Kaiser, Rolf, additional, Knops, Elena, additional, Silling, Steffi, additional, and Klein, Florian, additional

Published
2021
Full Text
View/download PDF

21. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody

Author

Schommers, Philipp, Gruell, Henning, Abernathy, Morgan E., Tran, My-Kim, Dingens, Adam S., Gristick, Harry B., Barnes, Christopher O., Schoofs, Till, Schlotz, Maike, Vanshylla, Kanika, Kreer, Christoph, Weiland, Daniela, Holtick, Udo, Scheid, Christof, Valter, Markus M., van Gils, Marit J., Sanders, Rogier W., Vehreschild, Joerg J., Cornely, Oliver A., Lehmann, Clara, Faetkenheuer, Gerd, Seaman, Michael S., Bloom, Jesse D., Bjorkman, Pamela J., Klein, Florian, Schommers, Philipp, Gruell, Henning, Abernathy, Morgan E., Tran, My-Kim, Dingens, Adam S., Gristick, Harry B., Barnes, Christopher O., Schoofs, Till, Schlotz, Maike, Vanshylla, Kanika, Kreer, Christoph, Weiland, Daniela, Holtick, Udo, Scheid, Christof, Valter, Markus M., van Gils, Marit J., Sanders, Rogier W., Vehreschild, Joerg J., Cornely, Oliver A., Lehmann, Clara, Faetkenheuer, Gerd, Seaman, Michael S., Bloom, Jesse D., Bjorkman, Pamela J., and Klein, Florian

Abstract

Broadly neutralizing antibodies (bNAbs) represent a promising approach to prevent and treat HIV-1 infection. However, viral escape through mutation of the HIV-1 envelope glycoprotein (Env) limits clinical applications. Here we describe 1-18, a new V(H)1-46-encoded CD4 binding site (CD4bs) bNAb with outstanding breadth (97%) and potency (GeoMean IC50 = 0.048 mu g/mL). Notably, 1-18 is not susceptible to typical CD4bs escape mutations and effectively overcomes HIV-1 resistance to other CD4bs bNAbs. Moreover, mutational antigenic profiling uncovered restricted pathways of HIV-1 escape. Of most promise for therapeutic use, even 1-18 alone fully suppressed viremia in HIV-1-infected humanized mice without selecting for resistant viral variants. A 2.5-angstrom cryo-EM structure of a 1-18-BG505(SOSIP.664) Env complex revealed that these characteristics are likely facilitated by a heavy-chain insertion and increased inter-protomer contacts. The ability of 1-18 to effectively restrict HIV-1 escape pathways provides a new option to successfully prevent and treat HIV-1 infection.

Published
2020

22. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody

Author

Schommers, Philipp Frederik, Gruell, Henning, Abernathy, Morgan E., Tran, My-Kim, Dingens, Adam S., Gristick, Harry B., Barnes, Christopher O., Schoofs, Till, Schlotz, Maike, Vanshylla, Kanika, Kreer, Christoph, Weiland, Daniela, Holtick, Udo, Scheid, Christof, Valter, Markus M., van Gils, Marit J., Sanders, Rogier W., Vehreschild, Jörg J., Cornely, Oliver A., Lehmann, Clara, Fätkenheuer, Gerd, Seaman, Michael S., Bloom, Jesse D., Bjorkman, Pamela J., Klein, Florian, Schommers, Philipp Frederik, Gruell, Henning, Abernathy, Morgan E., Tran, My-Kim, Dingens, Adam S., Gristick, Harry B., Barnes, Christopher O., Schoofs, Till, Schlotz, Maike, Vanshylla, Kanika, Kreer, Christoph, Weiland, Daniela, Holtick, Udo, Scheid, Christof, Valter, Markus M., van Gils, Marit J., Sanders, Rogier W., Vehreschild, Jörg J., Cornely, Oliver A., Lehmann, Clara, Fätkenheuer, Gerd, Seaman, Michael S., Bloom, Jesse D., Bjorkman, Pamela J., and Klein, Florian

Published
2020

23. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2

Author

Klein, Florian, primary, Vanshylla, Kanika, additional, Cristanziano, Veronica, additional, Kleipass, Franziska, additional, Dewald, Felix, additional, Schommers, Philipp, additional, Gieselmann, Lutz, additional, Gruell, Henning, additional, Schlotz, Maike, additional, Ercanoglu, Meryem, additional, Stumpf, Ricarda, additional, Mayer, Petra, additional, Heger, Eva, additional, Johannis, Wibke, additional, Horn, Carola, additional, Suárez, Isabelle, additional, Jung, Norma, additional, Salomon, Susanne, additional, Eberhardt, Kirsten, additional, Fätkenheuer, Gerd, additional, Pfeifer, Nico, additional, Eggeling, Ralf, additional, Augustin, Max, additional, and Lehmann, Clara, additional

Published
2021
Full Text
View/download PDF

24. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2

Author

Vanshylla, Kanika, primary, Di Cristanziano, Veronica, additional, Kleipass, Franziska, additional, Dewald, Felix, additional, Schommers, Philipp, additional, Gieselmann, Lutz, additional, Gruell, Henning, additional, Schlotz, Maike, additional, Ercanoglu, Meryem S, additional, Stumpf, Ricarda, additional, Mayer, Petra, additional, Heger, Eva, additional, Johannis, Wibke, additional, Horn, Carola, additional, Suárez, Isabelle, additional, Jung, Norma, additional, Salomon, Susanne, additional, Eberhardt, Kirsten Alexandra, additional, Fätkenheuer, Gerd, additional, Pfeifer, Nico, additional, Eggeling, Ralf, additional, Augustin, Max, additional, Lehmann, Clara, additional, and Klein, Florian, additional

Published
2021
Full Text
View/download PDF

25. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody

Author

Schommers, Philipp, primary, Gruell, Henning, additional, Abernathy, Morgan E., additional, Tran, My-Kim, additional, Dingens, Adam S., additional, Gristick, Harry B., additional, Barnes, Christopher O., additional, Schoofs, Till, additional, Schlotz, Maike, additional, Vanshylla, Kanika, additional, Kreer, Christoph, additional, Weiland, Daniela, additional, Holtick, Udo, additional, Scheid, Christof, additional, Valter, Markus M., additional, van Gils, Marit J., additional, Sanders, Rogier W., additional, Vehreschild, Jörg J., additional, Cornely, Oliver A., additional, Lehmann, Clara, additional, Fätkenheuer, Gerd, additional, Seaman, Michael S., additional, Bloom, Jesse D., additional, Bjorkman, Pamela J., additional, and Klein, Florian, additional

Published
2020
Full Text
View/download PDF

26. Safe and Effective Pool Testing for SARS-CoV-2 Detection

Author

Wunsch, Marie, primary, Aschemeier, Dominik, additional, Heger, Eva, additional, Ehrentraut, Denise, additional, Krüger, Jan, additional, Hufbauer, Martin, additional, Syed, Adnan Shahzad, additional, Horemheb-Rubio, Gibran, additional, Dewald, Felix, additional, Fish, Irina, additional, Schlotz, Maike, additional, Gruell, Henning, additional, Augustin, Max, additional, Lehmann, Clara, additional, Kaiser, Rolf, additional, Knops, Elena, additional, Silling, Steffi, additional, and Klein, Florian, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results